|
Market Closed -
Toronto S.E.
15:18:35 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.0500 CAD | -37.50% |
|
-.--% | -50.00% |
| Market Cap | 337K 245K 210K 198K 181K 23.21M 339K 2.35M 908K 11.86M 919K 899K 37.75M | P/E 2024 * |
-
| P/E 2025 | -2.96x |
|---|---|---|---|---|---|
| Enterprise Value | 337K 245K 211K 198K 181K 23.21M 339K 2.35M 908K 11.86M 919K 899K 37.76M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
39% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -37.50% | ||
| 1 month | -37.50% | ||
| 3 months | -16.67% | ||
| 6 months | -37.50% | ||
| Current year | -50.00% |
| 1 month | 0.05 | 0.08 | |
| Current year | 0.05 | 0.1 | |
| 1 year | 0.05 | 0.1 | |
| 3 years | 0 | 0.1 | |
| 5 years | 0 | 0.14 | |
| 10 years | 0 | 0.33 |
| Manager | Title | Age | Since |
|---|---|---|---|
Harry Katevatis
CEO | Chief Executive Officer | 84 | 2019-03-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Harry Katevatis
BRD | Director/Board Member | 84 | 2019-03-10 |
Vivian Katsuris
BRD | Director/Board Member | 61 | 2019-03-14 |
| Director/Board Member | 62 | 2024-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/7/20 | NGN Biomed Opportunity II LP
| Sell | Company | 125,000 | 2.7778% | |
| 5/7/20 | NGN Biomed Opportunity II LP
| Other | Company | 0 | 0% | - |
| 5/7/20 | NGN Biomed Opportunity II LP
| Sell | Company | 25,000 | 0.5556% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -37.50% | -.--% | -.--% | -52.38% | 153K | ||
| +1.01% | -48.33% | - | - | 1.71B | ||
| +1.49% | +4.21% | - | - | 758M | ||
| -0.05% | +0.10% | - | - | 648M | ||
| -0.24% | +0.10% | - | - | 601M | ||
| +0.56% | +0.19% | - | - | 598M | ||
| -0.38% | -0.29% | +2.37% | - | 592M | ||
| +2.41% | +10.41% | +266.21% | -78.00% | 599M | ||
| +0.53% | -0.69% | - | - | 567M | ||
| Average | -3.57% | -3.81% | +89.53% | -65.19% | 674.43M | |
| Weighted average by Cap. | +0.75% | -12.09% | +135.07% | -77.99% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -184K -134K -115K -108K -98.83K -12.69M -185K -1.28M -496K -6.49M -503K -492K -20.64M | -71.29K -51.75K -44.49K -41.86K -38.2K -4.91M -71.66K -496K -192K -2.51M -194K -190K -7.98M |
| Net Debt | -6.67K -4.84K -4.16K -3.92K -3.58K -459K -6.71K -46.43K -17.96K -235K -18.19K -17.79K -747K | 68 49.36 42.44 39.93 36.44 4.68K 68.35 473.09 183.03 2.39K 185.36 181.31 7.61K |
Employees
-
Sector
Investment Holding Companies
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- ZENI.P Stock
Select your edition
All financial news and data tailored to specific country editions
















